First Time Loading...

Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 72.545 USD -0.42% Market Closed
Updated: May 6, 2024
BSX
/
Income Statement
/
Revenue

Boston Scientific Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Boston Scientific Corp
Revenue Peer Comparison

Comparables:
BDX
SYK
ABT
ISRG
DXCM

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%
Dexcom Inc
NASDAQ:DXCM
Revenue
$3.8B
CAGR 3-Years
23%
CAGR 5-Years
28%
CAGR 10-Years
36%

Boston Scientific Corp
Revenue Breakdown

Breakdown by Geography
Boston Scientific Corp

Total Revenue: 14.2B USD
100%
Country_Us Excluding Other Net Sales: 8.4B USD
59.2%
United States: 8.4B USD
59.2%
Non-Us: 5.8B USD
40.8%
EMEA: 2.9B USD
20.1%
Apac: 2.4B USD
16.9%
Emerging Markets: 2.3B USD
16.2%
Latin America And Canada: 560m USD
3.9%
Show More
Show Less

Breakdown by Segments
Boston Scientific Corp

Total Revenue: 14.2B USD
100%
Cardiovascular: 8.8B USD
61.9%
Medsurg: 5.4B USD
38.1%

See Also

What is Boston Scientific Corp's Revenue?
Revenue
14.7B USD

Based on the financial report for Mar 31, 2024, Boston Scientific Corp's Revenue amounts to 14.7B USD.

What is Boston Scientific Corp's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Boston Scientific Corp have been 13% over the past three years , 8% over the past five years , and 7% over the past ten years .

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.